Campbell H, Byass P, Forgie I M, O'Neill K P, Lloyd-Evans N, Greenwood B M
Medical Research Council Laboratories, Fajara, The Gambia.
Lancet. 1988 Nov 19;2(8621):1182-4. doi: 10.1016/s0140-6736(88)90244-9.
134 Gambian children under 5 years of age with severe pneumonia (as defined by the World Health Organisation classification of acute respiratory infections) were given either oral co-trimoxazole for 5 days, or a single intramuscular dose of fortified procaine penicillin and 5 days of oral ampicillin. At 2 weeks, there was no significant difference in outcome between the two groups. Co-trimoxazole is much less expensive than ampicillin or procaine penicillin, requires only twice-daily administration, and can be given by health-care staff with little training. The results support the use of co-trimoxazole as the antibiotic of first choice in outpatient management of young children with pneumonia in developing countries.
134名5岁以下患有严重肺炎(根据世界卫生组织急性呼吸道感染分类定义)的冈比亚儿童,被给予为期5天的口服复方新诺明,或单次肌肉注射强化普鲁卡因青霉素及为期5天的口服氨苄青霉素。两周时,两组的治疗结果无显著差异。复方新诺明比氨苄青霉素或普鲁卡因青霉素便宜得多,只需每日服用两次,且经过很少培训的医护人员即可给药。这些结果支持在发展中国家将复方新诺明作为幼儿肺炎门诊治疗的首选抗生素。